Speciality: Gastroenterology
Description:
A warm welcome to all the medical professionals in this interesting session on Biologics in gastroenterology.
Biologics have revolutionized the treatment of several gastrointestinal disorders, particularly inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. These advanced therapies target specific molecules in the immune system, such as TNF-alpha or interleukins, which play key roles in the inflammation that drives these conditions. By reducing inflammation at the molecular level, biologics help control symptoms, promote healing of the gut lining, and prevent flare-ups.
In clinical practice, biologics like infliximab, adalimumab, and ustekinumab are used when conventional treatments fail to provide adequate relief. They have significantly improved the quality of life for patients with moderate to severe IBD, offering long-term disease control and reducing the need for surgery. Although biologics are highly effective, they do come with risks, including an increased chance of infections, requiring careful monitoring. As research advances, biologics continue to expand treatment options in gastroenterology, offering hope for patients with difficult-to-manage conditions.
Therefore, get an overall knowledge of Biologics in gastroenterology. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
5.
Microplastics can cause malignant changes in lung cells
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
5.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation